Literature DB >> 22200483

The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity.

Anna Villar-Pique1, Natalia S de Groot, Raimon Sabaté, Sergio P Acebrón, Garbiñe Celaya, Xavier Fernàndez-Busquets, Arturo Muga, Salvador Ventura.   

Abstract

The formation of aggregates by misfolded proteins is thought to be inherently toxic, affecting cell fitness. This observation has led to the suggestion that selection against protein aggregation might be a major constraint on protein evolution. The precise fitness cost associated with protein aggregation has been traditionally difficult to evaluate. Moreover, it is not known if the detrimental effect of aggregates on cell physiology is generic or depends on the specific structural features of the protein deposit. In bacteria, the accumulation of intracellular protein aggregates reduces cell reproductive ability, promoting cellular aging. Here, we exploit the cell division defects promoted by the intracellular aggregation of Alzheimer's-disease-related amyloid β peptide in bacteria to demonstrate that the fitness cost associated with protein misfolding and aggregation is connected to the protein sequence, which controls both the in vivo aggregation rates and the conformational properties of the aggregates. We also show that the deleterious impact of protein aggregation on bacterial division can be buffered by molecular chaperones, likely broadening the sequential space on which natural selection can act. Overall, the results in the present work have potential implications for the evolution of proteins and provide a robust system to experimentally model and quantify the impact of protein aggregation on cell fitness.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200483     DOI: 10.1016/j.jmb.2011.12.014

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Modeling amyloids in bacteria.

Authors:  Anna Villar-Piqué; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2012-12-28       Impact factor: 5.328

2.  Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.

Authors:  Anna Villar-Piqué; Alba Espargaró; Raimon Sabaté; Natalia S de Groot; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2012-05-03       Impact factor: 5.328

3.  The prion-like RNA-processing protein HNRPDL forms inherently toxic amyloid-like inclusion bodies in bacteria.

Authors:  Susanna Navarro; Patrizia Marinelli; Marta Diaz-Caballero; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2015-07-11       Impact factor: 5.328

4.  Factors that mediate and prevent degradation of the inactive and unstable GudB protein in Bacillus subtilis.

Authors:  Lorena Stannek; Katrin Gunka; Rachel A Care; Ulf Gerth; Fabian M Commichau
Journal:  Front Microbiol       Date:  2015-01-07       Impact factor: 5.640

5.  Mycobacterium tuberculosis CarD, an essential global transcriptional regulator forms amyloid-like fibrils.

Authors:  Gundeep Kaur; Soni Kaundal; Srajan Kapoor; Jonathan M Grimes; Juha T Huiskonen; Krishan Gopal Thakur
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

6.  The fitness cost and benefit of phase-separated protein deposits.

Authors:  Natalia Sanchez de Groot; Marc Torrent Burgas; Charles Nj Ravarani; Ala Trusina; Salvador Ventura; M Madan Babu
Journal:  Mol Syst Biol       Date:  2019-04-08       Impact factor: 11.429

7.  Protein aggregation profile of the human kinome.

Authors:  Ricardo Graña-Montes; Ricardo Sant'anna de Oliveira; Salvador Ventura
Journal:  Front Physiol       Date:  2012-11-20       Impact factor: 4.566

8.  Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.

Authors:  Bruno Macedo; Ricardo Sant'Anna; Susanna Navarro; Yraima Cordeiro; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2015-11-04       Impact factor: 5.328

Review 9.  Peptides as Potential Therapeutics for Alzheimer's Disease.

Authors:  Samo Ribarič
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.